NASDAQ$GEHC

GE HealthCare Technologies Inc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Reports in 2 weeks

GE HealthCare hasn't published Q2 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q1 2026

    Revenue
    $5.13B
    EPS
    $0.85
  • Year-ago · Q2 2024

    Q2 2024

    Revenue
    $4.84B
    EPS
    $0.93
  • FY2025 consensus

    Analyst consensus

    Revenue
    $20B
    EPS
    $4.69

Revenue & EPS history

GE HealthCare · Revenue · Quarterly

$5.13B

Q1 2026+7.4%vs Q1 2025
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Historical revenue by segment

GE HealthCare · $4.01B total across 4 segments · Q3 2023

  • Imaging
    $2.64B+4.7%
  • Patient Care
    $764M+9.0%
  • Pharma Diagnostics
    $589M+12.8%
  • Other
    $19M+35.7%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 15 quarterly earnings reports

Historical avg

-0.2%

Avg return

Earnings day

+0.2%

Avg return

5 days after

-0.3%

Avg return

30 days after

50%

8 / 16 earnings

Positive

+11.5%

Q4 2021

Best reaction

-12.9%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-12.9%-10.9%-8.9%
Q4 2025+6.4%+0.4%-5.7%
Q3 2025-2.7%-6.2%+0.7%
Q1 2025+3.3%+1.9%+3.6%
Q4 2024+8.8%+7.9%-4.6%
Q3 2024+2.4%+2.0%-2.4%
Q2 2024+0.9%-1.4%+2.6%
Q1 2024-12.0%-10.6%-11.7%
Q4 2021+11.5%+10.8%+26.2%
Q3 2023+8.1%+13.3%+8.4%
Q3 2022+8.1%+13.3%+8.4%
Q2 2023-4.0%-3.4%-15.1%
Q1 2023-8.7%-7.3%-9.0%
Q1 2022-8.7%-7.3%-9.0%
Q2 2022-2.3%+0.8%+4.4%
Q4 2022-0.8%+0.7%+7.4%
Q3 2021———
Q2 2021———
Q1 2021———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro